{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:02:51Z","timestamp":1791874971187,"version":"4.3.4"},"reference-count":380,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jaut.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T14:33:17Z","timestamp":1468593197000},"page":"41-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"special_numbering":"C","title":["The diagnosis and clinical management of the neuropsychiatric manifestations of lupus"],"prefix":"10.1016","volume":"74","author":[{"given":"M.","family":"Govoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bortoluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Padovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Silvagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Donelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ceruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.06.013_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Systemic Lupus International Collaborating Clinics (SLICC), Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0961203313512540","article-title":"Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"23","author":"Zirkzee","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780150512","article-title":"Criteria for the classification of systemic lupus erythematosus\u2014status 1972","volume":"15","author":"Cohen","year":"1972","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/art.1780221210","article-title":"Central nervous system lupus erythematosus. The need for classification","volume":"22","author":"Kassan","year":"1979","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/art.1780280710","article-title":"Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus","volume":"28","author":"How","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib7","first-page":"1397","article-title":"Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The Ad Hoc Neuropsychiatric Lupus Workshop Group","volume":"17","author":"Singer","year":"1990","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib11","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.semarthrit.2011.07.001","article-title":"Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus","volume":"41","author":"Barber","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib13","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0889-857X(21)00229-5","article-title":"Neuropsychiatric lupus","volume":"20","author":"West","year":"1994","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2016.06.013_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurological manifestations of systemic lupus erythematosus","volume":"47","author":"Johnson","year":"1968","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.rdc.2005.01.007","article-title":"Neuropsychiatric lupus","volume":"31","author":"Hanly","year":"2005","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2016.06.013_bib17","first-page":"194","article-title":"Neuropsychiatric lupus: clinical and imaging aspects","volume":"65","author":"Brey","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib18","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"32","author":"Hanly","year":"2005","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib21","first-page":"2156","article-title":"Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance","volume":"31","author":"Hanly","year":"2004","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Systemic Lupus International Collaborating Clinics, Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib23","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib24","first-page":"1536","article-title":"The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus","volume":"29","author":"Sibbitt","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1997.tb48379.x","article-title":"Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues","volume":"823","author":"Hanly","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0889-857X(21)00952-2","article-title":"Neuropsychiatric lupus","volume":"14","author":"McCune","year":"1988","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2016.06.013_bib27","first-page":"766","article-title":"Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus","volume":"28","author":"Mok","year":"2001","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2001.129","article-title":"FRI0094 the applicability of the american college of rheumatology nomenclature and case definition for neuropsychiatric lupus syndromes. analysis of 527 patients","volume":"60","author":"Costallat","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib29","first-page":"530","article-title":"European working party on systemic lupus erythematosus, lessons from the \u201cEuro-Lupus cohort\u201d","volume":"153","author":"Cervera","year":"2002","journal-title":"Ann. M\u00e9d. Interne"},{"key":"10.1016\/j.jaut.2016.06.013_bib30","first-page":"179","article-title":"Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus","volume":"20","author":"Kasitanon","year":"2002","journal-title":"Asian Pac. J. Allergy Immunol. Launched Allergy Immunol. Soc. Thail."},{"key":"10.1016\/j.jaut.2016.06.013_bib31","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3899\/jrheum.081133","article-title":"Prospective study of neuropsychiatric events in systemic lupus erythematosus","volume":"36","author":"Hanly","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0961203307085671","article-title":"Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients","volume":"17","author":"Zhou","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.md.0000231955.08350.1b","article-title":"Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus","volume":"85","author":"Mok","year":"2006","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib34","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.21271","article-title":"Cerebral and corpus callosum atrophy in systemic lupus erythematosus","volume":"52","author":"Appenzeller","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib35","first-page":"1776","article-title":"Cognitive function in a systemic lupus erythematosus inception cohort","volume":"35","author":"Petri","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib36","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar2184","article-title":"Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"9","author":"Hirohata","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib38","doi-asserted-by":"crossref","first-page":"e55843","DOI":"10.1371\/journal.pone.0055843","article-title":"Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients","volume":"8","author":"Kampylafka","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2016.06.013_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib40","doi-asserted-by":"crossref","first-page":"J254","DOI":"10.1016\/j.jaut.2011.12.001","article-title":"Sex differences and genomics in autoimmune diseases","volume":"38","author":"Amur","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.06.013_bib41","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/rheumatology\/ket160","article-title":"Effect of gender on clinical presentation in systemic lupus erythematosus","volume":"52","author":"Murphy","year":"2013","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-198509000-00001","article-title":"Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets","volume":"64","author":"Hochberg","year":"1985","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib43","first-page":"220","article-title":"Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations","volume":"17","author":"Ward","year":"1990","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1191\/0961203302lu161oa","article-title":"Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States","volume":"11","author":"Cooper","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib45","first-page":"1674","article-title":"Systemic lupus erythematosus disease severity in men and women: a case-control study","volume":"29","author":"Aranow","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib46","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/0961203311403640","article-title":"Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison","volume":"20","author":"Stefanidou","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-198309000-00005","article-title":"Systemic lupus erythematosus in males","volume":"62","author":"Miller","year":"1983","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096120339400300309","article-title":"SLE in Indian men: analysis of the clinical and laboratory features with a review of the literature","volume":"3","author":"Pande","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3899\/jrheum.111061","article-title":"Differences between male and female systemic lupus erythematosus in a multiethnic population","volume":"39","author":"Tan","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.rdc.2014.04.001","article-title":"Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus","volume":"40","author":"Gonz\u00e1lez","year":"2014","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2016.06.013_bib51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.22672","article-title":"A\u00a0multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE","volume":"57","author":"Fern\u00e1ndez","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/9612332lu155oa","article-title":"Baseline characteristics of a multiethnic lupus cohort: PROFILE","volume":"11","author":"Alarc\u00f3n","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11926-003-0022-8","article-title":"Ethnic disparities in patients with systemic lupus erythematosus","volume":"5","author":"Uribe","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2016.06.013_bib54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.50.7.490","article-title":"High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus","volume":"50","author":"Samanta","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/1529-0131(200112)45:6<494::AID-ART374>3.0.CO;2-M","article-title":"A\u00a0comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992","volume":"45","author":"Thumboo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib56","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1002\/art.34567","article-title":"European genetic ancestry is associated with a decreased risk of lupus nephritis","volume":"64","author":"Richman","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib57","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3899\/jrheum.080912","article-title":"Canadian network for improved outcomes in systemic lupus erythematosus (CaNIOS), the 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort","volume":"36","author":"Peschken","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0961203309104392","article-title":"Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort","volume":"18","author":"Gonz\u00e1lez","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0733-8619(05)70172-9","article-title":"Disorders that mimic central nervous system infections","volume":"17","author":"De Marcaida","year":"1999","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jaut.2016.06.013_bib60","first-page":"680","article-title":"Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus","volume":"27","author":"Rivest","year":"2000","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/ker310","article-title":"Italian Society of Rheumatology, Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients","volume":"51","author":"Govoni","year":"2012","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib62","first-page":"103","article-title":"Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion?","volume":"12","author":"Monov","year":"2008","journal-title":"Hippokratia"},{"key":"10.1016\/j.jaut.2016.06.013_bib63","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Systemic Lupus International Collaborating Clinics, Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.23566","article-title":"Systemic Lupus International Collaborating Clinics, Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study","volume":"59","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib65","first-page":"276","article-title":"Demystifying neuropsychiatric lupus\u2013is it possible?","volume":"67","author":"Hanly","year":"2009","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib66","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.38106","article-title":"Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study","volume":"65","author":"Hanly","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","volume":"54","author":"Bortoluzzi","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib68","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/rheumatology\/keu458","article-title":"Attribution in the assessment of nervous system disease in SLE","volume":"54","author":"Hanly","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib69","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib70","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib71","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.23098","article-title":"General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus","volume":"57","author":"Tomietto","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib72","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/annrheumdis-2011-201089","article-title":"Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study","volume":"71","author":"Hanly","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib73","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0961203314520843","article-title":"Neuropsychiatric systemic lupus erythematosus: association with global disease activity","volume":"23","author":"Morrison","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib74","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib75","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.62.9.859","article-title":"Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients","volume":"62","author":"Buj\u00e1n","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib76","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib77","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"67","author":"Hanly","year":"2015","journal-title":"Arthritis Rheumatol. Hob. N. J."},{"key":"10.1016\/j.jaut.2016.06.013_bib78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/0961203315624022","article-title":"Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study","volume":"25","author":"Gao","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib79","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10067-005-1166-x","article-title":"IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events","volume":"25","author":"Locht","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib80","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.amjcard.2005.02.010","article-title":"Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus","volume":"95","author":"Roldan","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib81","first-page":"622","article-title":"Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus","volume":"32","author":"Mok","year":"2005","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","article-title":"Predictors of cognitive dysfunction in patients with systemic lupus erythematosus","volume":"64","author":"McLaurin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib83","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","article-title":"Risk factors for central nervous system involvement in systemic lupus erythematosus","volume":"93","author":"Karassa","year":"2000","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"10.1016\/j.jaut.2016.06.013_bib85","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9343(00)00603-3","article-title":"Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"109","author":"Karassa","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/rheumatology\/keg078","article-title":"Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus","volume":"42","author":"Yee","year":"2003","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib87","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1191\/0961203302lu311rr","article-title":"Lowering anti-dsDNA antibodies\u2013what\u2019s new?","volume":"11","author":"Schiffer","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.10072","article-title":"Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage","volume":"46","author":"Brunner","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib89","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.21691","article-title":"Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus","volume":"64","author":"Murray","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib90","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/acr.21587","article-title":"Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus","volume":"64","author":"Katz","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib91","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/acr.20426","article-title":"Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus","volume":"63","author":"Julian","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0961203306074767","article-title":"Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients","volume":"16","author":"Tarr","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0961203307084724","article-title":"Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients","volume":"17","author":"Hereng","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib95","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.3899\/jrheum.120545","article-title":"Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy","volume":"39","author":"Zirkzee","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib96","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib97","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2016.06.013_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/0961203304lu1000rr","article-title":"Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"13","author":"Govoni","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib99","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.autrev.2007.11.022","article-title":"Optimizing clinical monitoring of central nervous system involvement in SLE","volume":"7","author":"Castellino","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ncprheum0726","article-title":"Neuropsychiatric systemic lupus erythematosus reconsidered","volume":"4","author":"S\u00e1nchez-Guerrero","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib101","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib102","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12016-007-8052-z","article-title":"Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management","volume":"34","author":"Rhiannon","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib103","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.11279","article-title":"Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement","volume":"48","author":"Trysberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/jhg.2011.49","article-title":"Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population","volume":"56","author":"Koga","year":"2011","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.jaut.2016.06.013_bib106","first-page":"745647","article-title":"Genetic factors in systemic lupus erythematosus: contribution to disease phenotype","volume":"2015","author":"Ceccarelli","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib107","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.autrev.2012.08.012","article-title":"Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?","volume":"12","author":"Fazzi","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib108","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib109","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.jaut.2016.06.013_bib110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/annrheumdis-2012-201760","article-title":"HLA-DRB1*04\/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus","volume":"72","author":"Lundstr\u00f6m","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jaut.2016.06.013_bib111","doi-asserted-by":"crossref","first-page":"ii56","DOI":"10.1136\/annrheumdis-2012-202351","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"72","author":"Rullo","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib112","first-page":"732","article-title":"Brain pathology in systemic lupus erythematosus","volume":"19","author":"Hanly","year":"1992","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib113","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.27458","article-title":"The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus","volume":"62","author":"Brooks","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jcp.46.1.37","article-title":"Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus","volume":"46","author":"Ellison","year":"1993","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.jaut.2016.06.013_bib115","first-page":"16658","article-title":"Role of IL-1\u03b2, IL-6, IL-8 and IFN-\u03b3 in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous, Int","volume":"8","author":"Wang","year":"2015","journal-title":"J.\u00a0Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib116","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A\u00a0meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib117","first-page":"268436","article-title":"Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus","volume":"2010","author":"Okamoto","year":"2010","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.jaut.2016.06.013_bib118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0361-9230(01)00428-2","article-title":"Cytokines and the central nervous system","volume":"54","author":"Szel\u00e9nyi","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jaut.2016.06.013_bib119","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","article-title":"Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus","volume":"27","author":"Chun","year":"2007","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib121","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/096120330000900704","article-title":"Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement","volume":"9","author":"Trysberg","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib122","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/art.20045","article-title":"Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities","volume":"50","author":"Ainiala","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib123","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1186\/ar1228","article-title":"Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement","volume":"6","author":"Trysberg","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib124","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.24603","article-title":"Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus","volume":"60","author":"Kwieci\u0144ski","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib125","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2741\/2864","article-title":"Chemokines in systemic lupus erythematosus involving the central nervous system","volume":"13","author":"Kasama","year":"2008","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"10.1016\/j.jaut.2016.06.013_bib126","doi-asserted-by":"crossref","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","author":"Yoshio","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib127","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.06.013_bib128","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bph.12337","article-title":"The TWEAK-Fn14 system as a potential drug target","volume":"170","author":"Wajant","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2016.06.013_bib129","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","article-title":"Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms","volume":"10","author":"George-Chandy","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0961203313496302","article-title":"Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus","volume":"22","author":"Vincent","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib131","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard.60.4.372","article-title":"Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus","volume":"60","author":"Svenungsson","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib132","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/s10165-009-0198-5","article-title":"Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers","volume":"19","author":"Efthimiou","year":"2009","journal-title":"Mod. Rheumatol. Jpn. Rheum. Assoc."},{"key":"10.1016\/j.jaut.2016.06.013_bib133","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198707303170503","article-title":"Association between lupus psychosis and anti-ribosomal P protein antibodies","volume":"317","author":"Bonfa","year":"1987","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib136","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9343(99)80135-1","article-title":"Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests","volume":"99","author":"West","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib137","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/096120339600500303","article-title":"Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody","volume":"5","author":"Watanabe","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","article-title":"Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study","volume":"32","author":"Briani","year":"2009","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.06.013_bib139","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.1780290906","article-title":"Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus","volume":"29","author":"Golombek","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib140","first-page":"1026","article-title":"Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study","volume":"18","author":"van Dam","year":"1991","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib141","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0002-9343(91)90506-S","article-title":"Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus","volume":"90","author":"Schneebaum","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib142","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/ard.51.4.489","article-title":"Antibodies to protein P in systemic lupus erythematosus","volume":"51","author":"Teh","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib143","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/32.4.287","article-title":"Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus","volume":"32","author":"Teh","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib144","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/ard.51.9.1053","article-title":"Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus","volume":"51","author":"Nojima","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib145","first-page":"1681","article-title":"Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus","volume":"22","author":"Yoshio","year":"1995","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib146","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.1780391109","article-title":"Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib147","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780390420","article-title":"Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis","volume":"39","author":"Press","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib148","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.1780390907","article-title":"Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus","volume":"39","author":"Isshi","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib149","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb48399.x","article-title":"Anti-P antibodies and neuropsychiatric lupus erythematosus","volume":"823","author":"Georgescu","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.59.2.99","article-title":"The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease","volume":"59","author":"Tzioufas","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib151","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","article-title":"Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients","volume":"41","author":"Gerli","year":"2002","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib152","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib153","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-008-0921-1","article-title":"Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus","volume":"27","author":"Abdel-Nasser","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib154","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/kep142","article-title":"Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus","volume":"48","author":"Haddouk","year":"2009","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib156","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib157","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheumatol. Hob. N. J."},{"key":"10.1016\/j.jaut.2016.06.013_bib158","first-page":"622","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib159","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.10.014","article-title":"Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion","volume":"626","author":"Barkus","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jaut.2016.06.013_bib160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2016.06.013_bib161","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.06.013_bib162","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.06.013_bib163","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A\u00a0subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib164","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/ard.2004.029280","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"64","author":"Husebye","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib165","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib166","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/art.21547","article-title":"Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus","volume":"54","author":"Yoshio","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib167","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.37745","article-title":"IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells","volume":"65","author":"Yoshio","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib168","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/art.22030","article-title":"Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus","volume":"54","author":"Harrison","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib169","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2010.04.016","article-title":"Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes","volume":"295","author":"Kozora","year":"2010","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib170","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.22031","article-title":"Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus","volume":"54","author":"Lapteva","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib171","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2016.00005","article-title":"Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Gerosa","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib172","doi-asserted-by":"crossref","first-page":"R366","DOI":"10.1186\/ar1198","article-title":"Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies","volume":"6","author":"Conti","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib173","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/art.20156","article-title":"Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Williams","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib174","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1002\/art.27700","article-title":"Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease","volume":"62","author":"Sato","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib175","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3927","article-title":"Autoantibody profiling to follow evolution of lupus syndromes","volume":"14","author":"Olsen","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib176","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/157015911796557984","article-title":"Neuropsychiatric systemic lupus erythematosus","volume":"9","author":"Popescu","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jaut.2016.06.013_bib177","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1529-0131(199805)41:5<918::AID-ART20>3.0.CO;2-W","article-title":"Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases","volume":"41","author":"Decker","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib178","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1074\/jbc.275.12.9043","article-title":"Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis","volume":"275","author":"Decker","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2016.06.013_bib179","doi-asserted-by":"crossref","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2016.06.013_bib180","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-009-1123-1","article-title":"Association of antiphosphatidylserine\/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus","volume":"28","author":"Syuto","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib181","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib182","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","article-title":"Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus","volume":"99","author":"Toubi","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib183","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02030510","article-title":"Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies","volume":"9","author":"Costallat","year":"1990","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib184","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/32.4.291","article-title":"Cognitive impairment and autoantibodies in systemic lupus erythematosus","volume":"32","author":"Hanly","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib185","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ard.55.8.544","article-title":"Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?","volume":"55","author":"Silva","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib186","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1297-319X(02)00366-4","article-title":"Autoantibodies to ribosomal P proteins in systemic lupus erythematosus","volume":"69","author":"Yalaoui","year":"2002","journal-title":"Jt. Bone Spine Rev. Rhum."},{"key":"10.1016\/j.jaut.2016.06.013_bib187","first-page":"34","article-title":"Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus","volume":"32","author":"Yoshio","year":"2005","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib188","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/03009740701482768","article-title":"Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations","volume":"36","author":"Magalh\u00e3es","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib189","first-page":"860","article-title":"Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus","volume":"18","author":"Karimifar","year":"2013","journal-title":"J.\u00a0Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.38.4.301","article-title":"The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms","volume":"38","author":"Bresnihan","year":"1979","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib191","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9343(81)90756-7","article-title":"Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"70","author":"Bluestein","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib192","first-page":"367","article-title":"Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without central nervous system involvement: the role of mycobacterial cross-reacting antigens","volume":"26","author":"Avinoach","year":"1990","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib193","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/096120339400300211","article-title":"Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement","volume":"3","author":"Mevorach","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib194","first-page":"267","article-title":"Detection of serum of IgG anti-neuronal antibodies in systemic lupus erythematosus patients with central nervous system manifestations","volume":"48","author":"Cojocaru","year":"2010","journal-title":"Romanian J. Intern. Med. Rev. Roum. M\u00e9d. Interne"},{"key":"10.1016\/j.jaut.2016.06.013_bib195","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1191\/0961203303lu501oa","article-title":"The blood-brain barrier in systemic lupus erythematosus","volume":"12","author":"Abbott","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib196","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2008.10.096","article-title":"MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion","volume":"449","author":"Kuhlmann","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jaut.2016.06.013_bib197","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2013.00484","article-title":"Neuropsychiatric lupus, the blood brain barrier, and the TWEAK\/Fn14 pathway","volume":"4","author":"Stock","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib198","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","article-title":"Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et\u2019s disease involving the nervous system","volume":"58","author":"McLean","year":"1995","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2016.06.013_bib199","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psyneuen.2007.12.007","article-title":"Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus","volume":"33","author":"Nishimura","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jaut.2016.06.013_bib200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuint.2006.08.005","article-title":"Systemic lupus erythematosus and the brain: what mice are telling us","volume":"50","author":"Alexander","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jaut.2016.06.013_bib201","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2005.04.022","article-title":"Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice","volume":"165","author":"Sidor","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(01)00412-X","article-title":"Immunoglobulin binding to brain in autoimmune mice","volume":"120","author":"Zameer","year":"2001","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2005.08.010","article-title":"Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease","volume":"169","author":"Sakic","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib204","first-page":"2010","article-title":"Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin","volume":"34","author":"Katsumata","year":"2007","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbi.2009.10.009","article-title":"Intrathecal antibodies and brain damage in autoimmune MRL mice","volume":"24","author":"Stanojcic","year":"2010","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jaut.2016.06.013_bib206","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib207","first-page":"1682","article-title":"C5a alters blood-brain barrier integrity in experimental lupus, FASEB J","volume":"24","author":"Jacob","year":"2010","journal-title":"Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jaut.2016.06.013_bib208","first-page":"5","article-title":"Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus","volume":"12","author":"Sfikakis","year":"1994","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib209","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"Spronk","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib210","first-page":"162","article-title":"Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus","volume":"4","author":"Sarbu","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.jaut.2016.06.013_bib211","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3899\/jrheum.071010","article-title":"Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus","volume":"35","author":"Petri","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib212","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12016-007-8060-z","article-title":"Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus","volume":"34","author":"Appenzeller","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2016.06.013_bib213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clineuro.2014.10.018","article-title":"Subarachnoid hemorrhage in systemic lupus erythematosus: systematic review and report of three cases","volume":"128","author":"Torn\u00e9","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jaut.2016.06.013_bib214","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib215","doi-asserted-by":"crossref","DOI":"10.1177\/0961203316643598","article-title":"Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus","author":"Ferreira","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib216","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2009.08.005","article-title":"Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus","volume":"40","author":"Sibbitt","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib217","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1), Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib218","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","article-title":"Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort","volume":"14","author":"Sarbu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib219","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3174\/ajnr.A3645","article-title":"Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome","volume":"35","author":"Kaichi","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mric.2015.11.002","article-title":"Magnetic resonance imaging of acute stroke","volume":"24","author":"Nael","year":"2016","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"10.1016\/j.jaut.2016.06.013_bib221","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203313477226","article-title":"Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythematosus","volume":"22","author":"Gao","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib222","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3174\/ajnr.A1740","article-title":"Identification of infarct core and penumbra in acute stroke using CT perfusion source images","volume":"31","author":"Wang","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib223","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1148\/radiol.2015150319","article-title":"Whole-brain CT perfusion to quantify acute ischemic penumbra and core","volume":"279","author":"Lin","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jaut.2016.06.013_bib224","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neurad.2008.03.005","article-title":"Cerebral perfusion CT: technique and clinical applications","volume":"35","author":"Wintermark","year":"2008","journal-title":"J.\u00a0Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12975-012-0178-5","article-title":"Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications","volume":"3","author":"d\u2019Esterre","year":"2012","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib226","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3171\/2013.10.JNS13103","article-title":"Clinical application of perfusion computed tomography in neurosurgery","volume":"120","author":"Huang","year":"2014","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.jaut.2016.06.013_bib227","doi-asserted-by":"crossref","first-page":"e0147910","DOI":"10.1371\/journal.pone.0147910","article-title":"Cerebral blood volume ASPECTS is the best predictor of clinical outcome in acute ischemic stroke: a retrospective, combined semi-quantitative and quantitative assessment","volume":"11","author":"Padroni","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2016.06.013_bib228","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/acr.21846","article-title":"Increased risk of subarachnoid hemorrhage in patients with systemic lupus erythematosus: a nationwide population-based study","volume":"65","author":"Chang","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2016.06.013_bib229","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/s10165-009-0206-9","article-title":"Subarachnoid hemorrhage in systemic lupus erythematosus in Japan: two case reports and a review of the literature","volume":"19","author":"Owada","year":"2009","journal-title":"Mod. Rheumatol. Jpn. Rheum. Assoc."},{"key":"10.1016\/j.jaut.2016.06.013_bib230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2152-7806.149617","article-title":"Rapid aneurysm growth and rupture in systemic lupus erythematosus","volume":"6","author":"Graffeo","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.jaut.2016.06.013_bib231","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.29.245","article-title":"Multiple saccular cerebral aneurysms associated with systemic lupus erythematosus\u2013case report","volume":"29","author":"Asai","year":"1989","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.jaut.2016.06.013_bib232","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/096120330000900708","article-title":"Subarachnoid hemorrhage and systemic lupus erythematosus","volume":"9","author":"Mimori","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib233","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib234","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J","article-title":"Neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"42","author":"Sibbitt","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib235","first-page":"2","article-title":"Diagnosis and management of acute myelopathies","volume":"11","author":"Kaplin","year":"2005","journal-title":"Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib236","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2008.09.002","article-title":"Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients","volume":"39","author":"Espinosa","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib237","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.rbr.2015.12.006","article-title":"Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients","volume":"56","author":"Costallat","year":"2016","journal-title":"Rev. Bras. Reumatol. Engl. Ed."},{"key":"10.1016\/j.jaut.2016.06.013_bib238","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2214\/ajr.144.5.1027","article-title":"MR imaging of systemic lupus erythematosus involving the brain","volume":"144","author":"Aisen","year":"1985","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.jaut.2016.06.013_bib239","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2377-12-152","article-title":"Posterior reversible encephalopathy syndrome could be an underestimated variant of \u201creversible neurological deficits\u201d in systemic lupus erythematosus","volume":"12","author":"Liu","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib240","first-page":"334","article-title":"Posterior reversible encephalopathy syndrome in systemic lupus erythematosus","volume":"19","author":"Gatla","year":"2013","journal-title":"J.\u00a0Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib241","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1552-6569.2001.tb00065.x","article-title":"Diagnostic value of apparent diffusion coefficient hyperintensity in selected patients with acute neurologic deficits","volume":"11","author":"Schaefer","year":"2001","journal-title":"J.\u00a0Neuroimaging Off. J. Am. Soc. Neuroimaging"},{"key":"10.1016\/j.jaut.2016.06.013_bib242","first-page":"1455","article-title":"Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome","volume":"22","author":"Provenzale","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib243","first-page":"1983","article-title":"Fluid attenuated inversion recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus","volume":"30","author":"Sibbitt","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib244","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","article-title":"Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients","volume":"64","author":"Appenzeller","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000093235","article-title":"Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications","volume":"22","author":"Ovbiagele","year":"2006","journal-title":"Cerebrovasc. Dis. Basel Switz."},{"key":"10.1016\/j.jaut.2016.06.013_bib246","first-page":"001140","article-title":"What are white matter hyperintensities made of? Relevance to vascular cognitive impairment","volume":"4","author":"Wardlaw","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jaut.2016.06.013_bib247","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/0961203315608256","article-title":"Brain unidentified bright objects (\u201cUBO\u201d) in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound","volume":"25","author":"Bortoluzzi","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib248","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.12669\/pjms.315.7975","article-title":"Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: a study at a tertiary care teaching hospital","volume":"31","author":"Parvez","year":"2015","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib249","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2015.01.010","article-title":"Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: factors associated with accrual of damage and central nervous system involvement","volume":"14","author":"Piga","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib250","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.4957","article-title":"FRI0384 usefulness of brain MRI in early lupus: how the morphological imaging changes at onset of the disease and after follow-up","volume":"74","author":"Silvagni","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib251","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"European task force on age-related white matter changes, A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke J. Cereb. Circ."},{"key":"10.1016\/j.jaut.2016.06.013_bib252","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00296-014-3150-8","article-title":"Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions","volume":"35","author":"Jeong","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.06.013_bib253","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/art.20654","article-title":"Selective gray matter damage in neuropsychiatric lupus","volume":"50","author":"Steens","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib254","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4103\/0366-6999.176996","article-title":"Relationship between clinical and immunological features with magnetic resonance imaging abnormalities in female patients with neuropsychiatric systemic lupus erythematosus","volume":"129","author":"Wang","year":"2016","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.jaut.2016.06.013_bib255","article-title":"The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities","author":"Hamcan","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib256","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2361040450","article-title":"Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging","volume":"236","author":"Geurts","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jaut.2016.06.013_bib257","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1371\/journal.pmed.0030499","article-title":"Selective involvement of the amygdala in systemic lupus erythematosus","volume":"3","author":"Emmer","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib258","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib259","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/CCO.0000000000000222","article-title":"Update on neurological paraneoplastic syndromes","volume":"27","author":"H\u00f6ftberger","year":"2015","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jaut.2016.06.013_bib260","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2016.06.013_bib261","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neurobiolaging.2004.05.004","article-title":"Measures of brain morphology and infarction in the framingham heart study: establishing what is normal","volume":"26","author":"DeCarli","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jaut.2016.06.013_bib262","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","article-title":"Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study","volume":"34","author":"Ainiala","year":"2005","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib263","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203313486193","article-title":"Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement","volume":"22","author":"Zivadinov","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib264","first-page":"3387","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sj\u00f6gren\u2019s syndrome, Arthritis Rheumatol","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Hob. N. J."},{"key":"10.1016\/j.jaut.2016.06.013_bib265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7","article-title":"Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"41","author":"Kozora","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib266","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuroimage.2006.09.029","article-title":"Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus","volume":"34","author":"Appenzeller","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.jaut.2016.06.013_bib267","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.1371\/journal.pone.0009302","article-title":"Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus","volume":"5","author":"Jung","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2016.06.013_bib268","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000117417","article-title":"Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging","volume":"37","author":"Scheltens","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib269","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/jnp.7.1.42","article-title":"Ventricular dilation, cortical atrophy, and neuropsychological outcome following traumatic brain injury","volume":"7","author":"Anderson","year":"1995","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jaut.2016.06.013_bib270","article-title":"Reduction of cerebral and corpus callosum volumes in childhood-onset systemic lupus erythematosus. A volumetric magnetic resonance imaging analysis","author":"Lapa","year":"2016","journal-title":"Arthritis Rheumatol. Hob. N. J."},{"key":"10.1016\/j.jaut.2016.06.013_bib271","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2005.049486","article-title":"Hippocampal atrophy in systemic lupus erythematosus","volume":"65","author":"Appenzeller","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2016.06.013_bib272","first-page":"S153","article-title":"Bleeding in the antiphospholipid syndrome","volume":"17","author":"Forastiero","year":"2012","journal-title":"Hematol. Amst. Neth."},{"key":"10.1016\/j.jaut.2016.06.013_bib273","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/2013.jamaneurol.505","article-title":"Cerebral microbleeds in lupus anticoagulant-hypoprothrombinemia syndrome","volume":"70","author":"Jadhav","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib274","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/STROKEAHA.115.011150","article-title":"Embolic stroke, atrial fibrillation, and microbleeds: is there a role for anticoagulation?","volume":"47","author":"Diener","year":"2016","journal-title":"Stroke J. Cereb. Circ."},{"key":"10.1016\/j.jaut.2016.06.013_bib275","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.005","article-title":"An up-to-date review on cerebral microbleeds","volume":"25","author":"Wu","year":"2016","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"10.1016\/j.jaut.2016.06.013_bib276","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3174\/ajnr.A2587","article-title":"Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications","volume":"33","author":"Agarwal","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib277","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.22228","article-title":"Magnetic resonance spectroscopy in the evaluation of central nervous system manifestations of systemic lupus erythematosus","volume":"55","author":"Appenzeller","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib278","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/ard.2004.026773","article-title":"Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up","volume":"64","author":"Castellino","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib279","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/0961203314534303","article-title":"Increased myo-inositol in parietal white and gray matter as a biomarker of poor prognosis in neuropsychiatric lupus: a case report","volume":"23","author":"Guillen-Del Castillo","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203313511556","article-title":"In\u00a0vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging","volume":"23","author":"Zimny","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib281","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.acra.2013.07.011","article-title":"Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study","volume":"20","author":"Cagnoli","year":"2013","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib282","first-page":"356","article-title":"Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns","volume":"25","author":"Jellison","year":"2004","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib283","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nicl.2014.07.001","article-title":"Diminished white matter integrity in patients with systemic lupus erythematosus","volume":"5","author":"Schmidt-Wilcke","year":"2014","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.jaut.2016.06.013_bib284","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/art.20512","article-title":"Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Bosma","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2377-10-65","article-title":"Diffusion tensor imaging in neuropsychiatric systemic lupus erythematosus","volume":"10","author":"Jung","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib286","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1002\/art.27717","article-title":"Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts","volume":"62","author":"Emmer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib287","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3174\/ajnr.A0831","article-title":"Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability","volume":"28","author":"Zaharchuk","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib288","first-page":"482","article-title":"Evaluation with MR, perfusion MR and cerebral flowSPECT in NPSLE patients","volume":"105","author":"Borrelli","year":"2003","journal-title":"Radiol. Med. (Torino)"},{"key":"10.1016\/j.jaut.2016.06.013_bib289","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jmri.22251","article-title":"Perfusion MRI in neuro-psychiatric systemic lupus erthemathosus","volume":"32","author":"Emmer","year":"2010","journal-title":"J.\u00a0Magn. Reson. Imaging JMRI"},{"key":"10.1016\/j.jaut.2016.06.013_bib290","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.acra.2012.03.023","article-title":"Perfusion-weighted MR imaging in cerebral lupus erythematosus","volume":"19","author":"Wang","year":"2012","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.jaut.2016.06.013_bib291","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002281-200109000-00007","article-title":"Imaging modalities in central nervous system systemic lupus erythematosus","volume":"13","author":"Huizinga","year":"2001","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib292","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiology.192.2.8029426","article-title":"Relaxivity and magnetization transfer of white matter lipids at MR imaging: importance of cerebrosides and pH","volume":"192","author":"Kucharczyk","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.jaut.2016.06.013_bib293","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nicl.2015.05.002","article-title":"A\u00a0multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus","volume":"8","author":"Ercan","year":"2015","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.jaut.2016.06.013_bib294","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semarthrit.2015.08.002","article-title":"Altered functional neuronal activity in neuropsychiatric lupus: a systematic review of the fMRI investigations","volume":"45","author":"Mikdashi","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib296","first-page":"1112","article-title":"Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement","volume":"38","author":"Lin","year":"1997","journal-title":"J.\u00a0Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib297","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.21591","article-title":"Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study","volume":"53","author":"Zhang","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib298","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0961203311415304","article-title":"Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study","volume":"20","author":"Castellino","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib299","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/0961203312459104","article-title":"The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings","volume":"21","author":"Lee","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib301","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/art.30458","article-title":"Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus","volume":"63","author":"Ramage","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib302","doi-asserted-by":"crossref","first-page":"e000074","DOI":"10.1136\/lupus-2014-000074","article-title":"Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus","volume":"2","author":"Mackay","year":"2015","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib303","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0b013e328363eaf1","article-title":"Pathogenesis and treatment of CNS lupus","volume":"25","author":"Fanouriakis","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib304","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib305","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/138161208799316401","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach","volume":"14","author":"Sanna","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jaut.2016.06.013_bib306","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib307","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib308","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780210103","article-title":"Migrainous phenomena in systemic lupus erythematosus","volume":"21","author":"Brandt","year":"1978","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib309","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/art.11299","article-title":"Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator","volume":"48","author":"Baker","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib310","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","article-title":"BLISS-52 and BLISS-76 Study Groups, Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","volume":"71","author":"Manzi","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib311","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0961203313477227","article-title":"Depression and systemic lupus erythematosus: a systematic review","volume":"22","author":"Palagini","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib312","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00296-011-2043-3","article-title":"Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience","volume":"32","author":"Xie","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.06.013_bib313","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/art.24236","article-title":"Depression, medication adherence, and service utilization in systemic lupus erythematosus","volume":"61","author":"Julian","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib314","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/art.20533","article-title":"Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial","volume":"51","author":"Greco","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib315","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2648.2003.02647.x","article-title":"Effects of a self-management course for patients with systemic lupus erythematosus","volume":"42","author":"Sohng","year":"2003","journal-title":"J.\u00a0Adv. Nurs."},{"key":"10.1016\/j.jaut.2016.06.013_bib316","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000276370","article-title":"Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial","volume":"79","author":"Navarrete-Navarrete","year":"2010","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jaut.2016.06.013_bib317","first-page":"298","article-title":"Effect of psychological intervention on health-related quality of life in people with systemic lupus erythematosus: a systematic review","volume":"1","author":"Liang","year":"2014","journal-title":"Int. J. Nurs. Sci."},{"key":"10.1016\/j.jaut.2016.06.013_bib318","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib319","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.wnl.0000180938.69146.5e","article-title":"Results of intervention for lupus patients with self-perceived cognitive difficulties","volume":"65","author":"Harrison","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib320","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/art.20279","article-title":"A\u00a0randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus","volume":"50","author":"Karlson","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib321","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1207\/S15324796ABM2402_05","article-title":"Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus","volume":"24","author":"Dobkin","year":"2002","journal-title":"Ann. Behav. Med. Publ. Soc. Behav. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib322","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","article-title":"Predictors of cognitive dysfunction in patients with systemic lupus erythematosus","volume":"64","author":"McLaurin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib323","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.semarthrit.2011.06.004","article-title":"Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence","volume":"41","author":"Narv\u00e1ez","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib324","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semarthrit.2011.02.005","article-title":"Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial","volume":"41","author":"Petri","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib325","first-page":"780","article-title":"Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy","volume":"28","author":"Borba","year":"2001","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib326","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/annrheumdis-2013-203933","article-title":"Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","volume":"74","author":"Parker","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib327","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib328","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/ket313","article-title":"Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)","volume":"53","author":"Cuadrado","year":"2014","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib329","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0961203315581207","volume":"24","author":"Cohen","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib331","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0961203315622821","article-title":"Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study","volume":"25","author":"Fanouriakis","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib332","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0961203307079044","article-title":"Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials","volume":"16","author":"Ad Hoc Committee on Lupus Response Criteria: Cognition Sub-committee","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib333","unstructured":"Diagnostic and Statistical Manual of Mental Disorders Source Information, (n.d.). https:\/\/www.nlm.nih.gov\/research\/umls\/sourcereleasedocs\/current\/DSM4\/ (accessed May 11, 2016)."},{"key":"10.1016\/j.jaut.2016.06.013_bib334","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.61.1.104","article-title":"Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus","volume":"61","author":"Chau","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib335","first-page":"2150","article-title":"New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study","volume":"261","author":"Nishimura","year":"2014","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib336","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00296-013-2750-z","article-title":"Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus","volume":"33","author":"Bhangle","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.06.013_bib337","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jama.1979.03290360027021","article-title":"Lithium prophylaxis of corticotropin-induced psychosis","volume":"241","author":"Falk","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2016.06.013_bib338","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0163-8343(94)90086-8","article-title":"Chlorpromazine prophylaxis of steroid-induced psychosis","volume":"16","author":"Bloch","year":"1994","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jaut.2016.06.013_bib339","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","article-title":"Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease","volume":"47","author":"Pego-Reigosa","year":"2008","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib340","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-016-0331-x","article-title":"Beyond clinical remission in first episode psychosis: thoughts on antipsychotic maintenance vs. guided discontinuation in the functional recovery era","author":"Alvarez-Jimenez","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaut.2016.06.013_bib341","first-page":"295","article-title":"Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Ramos","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib342","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9343(99)80078-3","article-title":"Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus","volume":"98","author":"Neuwelt","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib343","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/qjmed\/81.3.975","article-title":"Pulse cyclophosphamide for severe neuropsychiatric lupus","volume":"81","author":"Boumpas","year":"1991","journal-title":"Q.\u00a0J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib344","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(03)00135-9","article-title":"Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study","volume":"115","author":"Mok","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.06.013_bib345","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4081\/reumatismo.2012.350","article-title":"Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre","volume":"64","author":"Bortoluzzi","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.jaut.2016.06.013_bib346","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib347","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0961203307088005","article-title":"Prognostic factors of lupus myelopathy","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib348","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib349","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib350","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.06.013_bib351","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-1331.2010.03208.x","article-title":"Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation","volume":"18","author":"Katsiari","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2016.06.013_bib352","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","article-title":"Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?","volume":"44","author":"Ferreira","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2016.06.013_bib353","first-page":"CD005594","article-title":"Antipsychotics for delirium","author":"Lonergan","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib354","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jaut.2016.06.013_bib355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-0172(87)90003-5","article-title":"Chorea in systemic lupus erythematosus and \u201clupus-like\u201d disease: association with antiphospholipid antibodies","volume":"16","author":"Asherson","year":"1987","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib356","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","article-title":"Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review","volume":"87","author":"Lin","year":"2009","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.jaut.2016.06.013_bib357","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bjo.81.2.130","article-title":"Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide","volume":"81","author":"Rosenbaum","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2016.06.013_bib358","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/qjmed\/hcl125","article-title":"Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome","volume":"100","author":"Mathew","year":"2007","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"10.1016\/j.jaut.2016.06.013_bib359","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2011.04.001","article-title":"Peripheral neuropathy in patients with systemic lupus erythematosus","volume":"41","author":"Florica","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib360","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib361","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib362","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol. Zurich Switz."},{"key":"10.1016\/j.jaut.2016.06.013_bib363","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib364","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-065X.2008.00627.x","article-title":"Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis","volume":"223","author":"Silverman","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1352458514561911","article-title":"The Charcot Lecture | beating MS: a story of B cells, with twists and turns","volume":"21","author":"Hauser","year":"2015","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.jaut.2016.06.013_bib366","first-page":"449","article-title":"Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry","volume":"33","author":"Iaccarino","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"35","key":"10.1016\/j.jaut.2016.06.013_bib367","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1358\/dot.1999.35.7.548264","article-title":"Immunomodulation of various autoimmune diseases by intravenous immunoglobulin","volume":"1998","author":"Sherer","year":"1999","journal-title":"Drugs Today Barc. Spain"},{"key":"10.1016\/j.jaut.2016.06.013_bib368","first-page":"41","article-title":"Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre","volume":"32","author":"Camara","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.06.013_bib369","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e31824de293","article-title":"Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the therapeutics and technology Assessment Subcommittee of the American Academy of Neurology","volume":"78","author":"Patwa","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.06.013_bib370","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2015.08.010","article-title":"Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review","volume":"15","author":"Kronbichler","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.06.013_bib371","first-page":"173","article-title":"The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Neuwelt","year":"2003","journal-title":"Ther. Apher. Dial. Off. Peer Rev. J. Int. Soc. Apher. Jpn. Soc. Apher. Jpn. Soc. Dial. Ther."},{"key":"10.1016\/j.jaut.2016.06.013_bib372","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/art.1780371212","article-title":"Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide","volume":"37","author":"Euler","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib373","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jca.2920060109","article-title":"Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG)","volume":"6","author":"Clark","year":"1991","journal-title":"J.\u00a0Clin. Apher."},{"key":"10.1016\/j.jaut.2016.06.013_bib374","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2016.06.013_bib375","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2016.06.013_bib376","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1705579","article-title":"Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation","volume":"39","author":"Statkute","year":"2007","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.jaut.2016.06.013_bib377","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/0961203303lu251oa","article-title":"Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)","volume":"12","author":"Stojanovich","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.06.013_bib378","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.10752","article-title":"High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus","volume":"48","author":"Petri","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.06.013_bib379","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00197524","article-title":"Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate","volume":"16","author":"Valesini","year":"1994","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2016.06.013_bib380","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s12013-014-0010-9","article-title":"Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection","volume":"70","author":"Wang","year":"2014","journal-title":"Cell Biochem. Biophys."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:57Z","timestamp":1760256957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":380,"alternative-id":["S0896841116300919"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.06.013","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnosis and clinical management of the neuropsychiatric manifestations of lupus","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}